The Biotech Growth Trust PLC (BIOG.L)
GBp 879.0
(0.34%)
GBp 879.0
(0.34%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | - GBP | 1499.2% |
| 2022 | - GBP | -98.62% |
| 2021 | -10.72 Million GBP | -188.6% |
| 2020 | - GBP | 173.3% |
| 2019 | - GBP | -3.03% |
| 2018 | -3.2 Million GBP | 86.16% |
| 2017 | 2.38 Million GBP | -129.39% |
| 2016 | -280 Thousand GBP | 177.02% |
| 2015 | -340 Thousand GBP | -159.83% |
| 2014 | - GBP | 147.96% |
| 2013 | - GBP | 13.51% |
| 2012 | 92 Thousand GBP | 87.91% |
| 2011 | 24.45 Million GBP | 1916.15% |
| 2010 | 2.01 Million GBP | -92.99% |
| 2009 | - GBP | 58.96% |
| 2008 | - GBP | 303.13% |
| 2007 | - GBP | -1306.24% |
| 2006 | - GBP | -91.14% |
| 2005 | - GBP | 372.55% |
| 2004 | - GBP | -121.77% |
| 2003 | - GBP | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 FY | - GBP | 1499.2% |
| 2023 Q1 | -702.5 Thousand GBP | -4232.35% |
| 2023 Q4 | -165.5 Thousand GBP | 0.0% |
| 2023 Q3 | -165.5 Thousand GBP | -299.4% |
| 2023 Q2 | 83 Thousand GBP | 111.81% |
| 2022 Q4 | 17 Thousand GBP | -96.65% |
| 2022 FY | - GBP | -98.62% |
| 2022 Q2 | 39 Thousand GBP | 101.4% |
| 2022 Q1 | -2.78 Million GBP | -3761.18% |
| 2022 Q3 | 507 Thousand GBP | 1200.0% |
| 2021 Q2 | 73 Thousand GBP | 115.05% |
| 2021 Q4 | 76 Thousand GBP | 109.84% |
| 2021 FY | - GBP | -188.6% |
| 2021 Q1 | -485 Thousand GBP | -869.84% |
| 2021 Q3 | -772.5 Thousand GBP | -1158.22% |
| 2020 Q2 | 68 Thousand GBP | -92.65% |
| 2020 Q1 | 925.5 Thousand GBP | 834.85% |
| 2020 FY | - GBP | 173.3% |
| 2020 Q4 | 63 Thousand GBP | -90.76% |
| 2020 Q3 | 682 Thousand GBP | 902.94% |
| 2019 FY | - GBP | -3.03% |
| 2019 Q2 | -1 Million GBP | 0.0% |
| 2019 Q4 | 99 Thousand GBP | 112.79% |
| 2019 Q3 | -774 Thousand GBP | 23.14% |
| 2019 Q1 | -1 Million GBP | -291.83% |
| 2018 Q2 | -1.34 Million GBP | 0.0% |
| 2018 Q4 | -257 Thousand GBP | 0.0% |
| 2018 FY | - GBP | 86.16% |
| 2018 Q1 | -1.34 Million GBP | -2669.07% |
| 2018 Q3 | -257 Thousand GBP | 80.86% |
| 2017 Q3 | -48.5 Thousand GBP | -103.9% |
| 2017 FY | - GBP | -129.39% |
| 2017 Q1 | 1.24 Million GBP | 514.33% |
| 2017 Q2 | 1.24 Million GBP | 0.0% |
| 2017 Q4 | -48.5 Thousand GBP | 0.0% |
| 2016 FY | - GBP | 177.02% |
| 2016 Q4 | -300 Thousand GBP | 0.0% |
| 2016 Q3 | -300 Thousand GBP | 68.94% |
| 2016 Q2 | -966 Thousand GBP | 0.0% |
| 2016 Q1 | -966 Thousand GBP | 27.34% |
| 2015 Q4 | -1.32 Million GBP | 0.0% |
| 2015 FY | - GBP | -159.83% |
| 2015 Q1 | 258.5 Thousand GBP | 112.36% |
| 2015 Q2 | 258.5 Thousand GBP | 0.0% |
| 2015 Q3 | -1.32 Million GBP | -614.31% |
| 2014 Q3 | -2.09 Million GBP | -402.77% |
| 2014 Q2 | -415.99 Thousand GBP | 0.0% |
| 2014 Q1 | -415.99 Thousand GBP | -224.36% |
| 2014 Q4 | -2.09 Million GBP | 0.0% |
| 2014 FY | - GBP | 147.96% |
| 2013 FY | - GBP | 13.51% |
| 2013 Q1 | 453.5 Thousand GBP | 211.68% |
| 2013 Q2 | 453.5 Thousand GBP | 0.0% |
| 2013 Q4 | 334.5 Thousand GBP | 0.0% |
| 2013 Q3 | 334.5 Thousand GBP | -26.24% |
| 2012 Q3 | 145.5 Thousand GBP | 226.52% |
| 2012 FY | - GBP | 87.91% |
| 2012 Q1 | -115 Thousand GBP | 0.0% |
| 2012 Q2 | -115 Thousand GBP | 0.0% |
| 2012 Q4 | 145.5 Thousand GBP | 0.0% |
| 2011 Q4 | - GBP | 0.0% |
| 2011 Q2 | - GBP | 0.0% |
| 2011 FY | - GBP | 1916.15% |
| 2010 Q4 | - GBP | 0.0% |
| 2010 FY | - GBP | -92.99% |
| 2010 Q2 | - GBP | 0.0% |
| 2009 Q2 | - GBP | 0.0% |
| 2009 FY | - GBP | 58.96% |
| 2009 Q4 | - GBP | 0.0% |
| 2008 Q4 | - GBP | 0.0% |
| 2008 Q2 | - GBP | 0.0% |
| 2008 FY | - GBP | 303.13% |
| 2007 Q4 | - GBP | 0.0% |
| 2007 Q2 | - GBP | 0.0% |
| 2007 FY | - GBP | -1306.24% |
| 2006 Q4 | - GBP | 0.0% |
| 2006 FY | - GBP | -91.14% |
| 2006 Q2 | - GBP | 0.0% |
| 2005 Q4 | - GBP | 0.0% |
| 2005 Q2 | - GBP | 0.0% |
| 2005 FY | - GBP | 372.55% |
| 2004 Q2 | - GBP | 0.0% |
| 2004 FY | - GBP | -121.77% |
| 2004 Q4 | - GBP | 0.0% |
| 2003 FY | - GBP | 0.0% |
| 2003 Q4 | - GBP | 0.0% |
| 2003 Q2 | - GBP | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|